
IN THE NEWS
Duke #3 for Scientific Research according to Nature Index
High levels of cancer-causing chemical found in mint and menthol e-cigarettes: Study (ABC News)
Sairam Jabba, DVM, PhD, and Sven-Eric Jordt, PhD
Conway Medical Center opens new cancer center (myhorrynews.com)
Features Duke Cancer Network
Duke researchers utilize gene editing to improve cancer drugs’ performance (WRAL Techwire/Pratt School of Engineering)
Ashutosh Chilkoti, PhD
Greensboro firefighters wearing special wristbands to analyze chemicals they are exposed to (FOX 8 Greensboro)
Features Steven Patierno, PhD
Could home care replace inpatient HSCT? (Hematology News)
Features Nelson Chao, MD
NIH Awards $2.5 Million For Prostate Cancer Research (DCI Center for Prostate & Urologic Cancers)
Features Andrew Armstrong, MD
The Kidney Cancer Association Announces Recipients for the Advanced Discovery Awards and Young Investigator Awards (Kidney Cancer Association)
Features Tian Zhang, MD, and Daniel George, MD
Zhang 2019 KCA Young Investigator Award (DCI Center for Prostate & Urologic Cancers)
Features Tian Zhang, MD
For Some Women with Breast Cancer, Cost Influences Decisions about Surgery (NCI)
Features Rachel Greenup, MD
Altering Diet Enhances Response to Cancer Treatments in Mice (NCI)
Features Jason Locasale, PhD
ASTRO Unveils First RT Guideline for Pancreatic Cancer — Radiation's role in pancreatic cancer is "controversial," says guideline author (MedPage Today)
Features Manisha Palta, MD
ASTRO shares new guidelines on pancreatic cancer treatment (Radiology Business)
Features Manisha Palta, MD
Envisioning the Future of Cancer (National Cancer Institute)
Tomi Akinyemiju, PhD
Nivolumab still has edge on chemo after 4 years in advanced NSCLC (Reuters/Journal of Clinical Pathways)
Features Scott Antonia, MD
Many Choices Now for Men With Metastatic Hormone-Sensitive Prostate Cancer: How to Decide? (ASCO Post)
Features Andrew Armstrong, MD
Cancer Slayer of the Month (Prelude to a Cure)
Features Scott Antonia, MD
Anything but Black and White - Racial Disparities in Prostate Cancer (Uro Today)
Features Daniel George, MD
Although Barriers to Treating Brain Metastases Exist, Systemic Therapies Make Progress (Targeted Oncology)
Features Carey Anders, MD
WATCH: Expert Advice for Newly Diagnosed CLL Patients (Patient Empowerment Network)
Features Danielle Brander, MD
WATCH: The Benefits of Seeking a Second Opinion in Myeloma (Patient Empowerment Network)
Features Cristina Gasparetto, MD
Social Disparities in Radiation Therapy (ONS Voice)
Features John Hillson RN, BSN, OCN
The top 5 healthcare institutions for scientific research in 2018 (Nature Index)
Duke University Health System ranked number 3 among top 5 healthcare institutions for scientific research in 2018
Blue Devil of the Week: Helping Patients Take Steps Toward Healing (Duke Today)
Features Dana Lott (Duke Neurology physical therapist)
Jason Locasale: Fighting cancer with chemical complexity and collaboration (The Chronicle)
To catch up on all the newsmakers and papers you may have missed over the summer, read August Newsmakers and July Newsmakers.
What's so different about bloodcancers, when it comes to palliative care?
The KRISTINE Trial in HER2+ Breast Cancer
Biomarkers: Guide to Clinical Decision Making to Treat mRCC
Papers
Genomically Informed Small Molecule Drugs Overcome Resistance to a Sustained Release Formulation of an Engineered Death Receptor Agonist in Patient-Derived Tumor Models. Science Advances. 2019. Mandana T. Manzari, Grace R. Anderson, Kevin H. Lin, Ryan S. Soderquist, Merve Cakir, Mitchell Zhang, Chandler E. Moore, Rachel N. Skelton, Mareva Fevre, Xinghai Li, Joseph J. Bellucci, Suzanne E. Wardell, Simone A. Costa, Kris C. Wood, Ashutosh Chilkoti.
Retrospective analysis of safety and efficacy of anti-PD-1 therapy and radiation therapy in advanced melanoma: A bi-institutional study. Radiotherapy & Oncology. Sept. 2019.
Mowery YM, Patel K, Chowdhary M, Rushing CN, Roy Choudhury K, Lowe JR, Olson AC, Wisdom AJ, Salama JK, Hanks BA, Khan MK, Salama AKS.
Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide. Supportive Care in Cancer. Aug. 22, 2019. Mallika P. Patel, Sarah Woodring, Dina M. Randazzo, Henry S. Friedman, Annick Desjardins, Patrick Healy, James E. Herndon II, Frances McSherry, Eric S. Lipp, Elizabeth Miller, Katherine B. Peters, Mary Lou Affronti.